Trump's Pharma Deals: $733B in Savings, But Critics Question Details

Summary

White House economists project massive savings from Trumps pharma deals, potentially saving $529 billion over ten years and $64.3 billion in Medicaid savings. However, critics question full disclosure and long-term savings as drug spending hits $467 billion in 2024. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:a…

Show notes

White House economists project massive savings from Trumps pharma deals, potentially saving $529 billion over ten years and $64.3 billion in Medicaid savings. However, critics question full disclosure and long-term savings as drug spending hits $467 billion in 2024. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:advertise@thednn.ai This is an automated, high-level news summary based on public reporting.Report issues to feedback@thednn.ai. View sources &

Themes

• ai
• daily